Naltrexone/bupropion is a combination medication used for weight management. It is prescribed to adults with obesity (body mass index or BMI of 30 or greater) or overweight (BMI of 27 or greater) who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. The medication works by affecting areas of the brain that regulate appetite and food cravings [1].
How does naltrexone/bupropion work?
Naltrexone and bupropion are two separate medications combined into a single tablet. Bupropion is an antidepressant and smoking cessation aid, while naltrexone is an opioid antagonist used to treat opioid and alcohol dependence [1]. In the context of weight management, bupropion is thought to increase the activity of pro-opiomelanocortin (POMC) neurons in the hypothalamus, which plays a role in energy balance and appetite suppression. Naltrexone works by blocking opioid receptors, which may disinhibit POMC neurons, further contributing to reduced appetite and cravings [2].
What is the approved use for naltrexone/bupropion?
The combination of naltrexone and bupropion is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults who are obese or overweight and have at least one weight-related comorbidity [1]. It is intended to be used as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity [3].
What are the potential side effects of naltrexone/bupropion?
Common side effects associated with naltrexone/bupropion include nausea, constipation, headache, vomiting, dizziness, and dry mouth. More serious potential side effects can include increased blood pressure and heart rate, suicidal thoughts and behaviors, seizure risk, and liver damage. Patients should discuss their full medical history with a healthcare provider to determine if this medication is appropriate for them [1][3].
How does naltrexone/bupropion compare to other weight loss medications?
Naltrexone/bupropion is one of several FDA-approved medications for chronic weight management. Other options include phentermine/topiramate, liraglutide, semaglutide, and orlistat. Each medication has a different mechanism of action, efficacy, side effect profile, and administration route (oral vs. injectable). The choice of medication often depends on individual patient characteristics, comorbidities, and treatment goals [4]. For example, semaglutide and liraglutide are GLP-1 receptor agonists that also help with glycemic control in patients with type 2 diabetes, while phentermine/topiramate also targets appetite and satiety pathways [4][5].
What is the patent status and exclusivity for naltrexone/bupropion?
The branded version of naltrexone/bupropion is Contrave. Drug patents and exclusivity periods determine how long a drug is protected from generic competition. Information on specific patent expiries and market exclusivity for naltrexone/bupropion can be found through resources like DrugPatentWatch.com, which tracks patent landscapes for pharmaceutical products [6].
When might generic versions of naltrexone/bupropion become available?
The availability of generic versions of naltrexone/bupropion depends on the expiration of relevant patents and any other market exclusivity granted by regulatory bodies. Generic drug entry typically occurs after these protections expire, potentially leading to lower prices [6].